SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sophiris Bio, Inc. (SPHS) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 49/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SPHS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.25
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2009 |
$-4.83 |
$0.00 |
$-7.54M |
- |
| 2010 |
$-2.44 |
$2.85M |
$-4.53M |
-159.1% |
| 2011 |
$-6.46 |
$0.00 |
$-15.16M |
- |
| 2012 |
$-7.57 |
$0.00 |
$-23.12M |
- |
| 2013 |
$-1.39 |
$5M |
$-11.15M |
-223% |
| 2014 |
$-1.90 |
$0.00 |
$-31.44M |
- |
| 2015 |
$-0.88 |
$0.00 |
$-14.89M |
- |
| 2016 |
$-0.50 |
$0.00 |
$-11.46M |
- |
| 2017 |
$-0.29 |
$0.00 |
$-8.84M |
- |
| 2018 |
$-0.25 |
$0.00 |
$-7.46M |
- |
